WHEREAS:Registration Rights Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
EX-10.3 [HemoBioTech logo] AMENDED EMPLOYMENT AGREEMENT This Amended Employment Agreement (the "Agreement") is effective as of October 6, 2003, by and between HemoBioTech Inc., a Texas corporation (the "Company"), and Arthur P. Bollon, Ph.D. (the...Employment Agreement • April 15th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances) • Texas
EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is effective as of January 1, 2005, by and between Hemobiotech, Inc., a Delaware corporation (the "Company"), and Robert Comer (the "Executive") WHEREAS, Executive is a consultant acting...Employment Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
ANDStockholders' Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
HEMOBIOTECH LOGO] EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement ") is effective as of April 1, 2005, by and between Hemobiotech Inc., a Delaware corporation (the "Company"), and Mark J. Rosenblum (the "Executive"). WHEREAS, the...Employment Agreement • April 15th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances) • Texas
Ex-9.1 VOTING AGREEMENT VOTING AGREEMENT (this "AGREEMENT") entered into on this 15th day of July, 2004, by and among GHASSAN NINO, a stockholder and Vice Chairman ("Nino") of Hemobiotech Inc., a Delaware corporation (the "Company"), NINO PARTNERS,...Voting Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
WITNESSETH ----------License Agreement • May 13th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances) • Texas
Exhibit 10.12 Confidential portions of this Agreement have been omitted pursuant to an order granting confidential treatment issued by the Commission on May 11, 2005, pursuant to Rule 406 of the Securities Act of 1933, as amended. [TEXAS TECH...Patent License Agreement • May 13th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances)
Exhibit 10.17 HemoBioTech[Graphic Omitted] 2110 Research Row Suite 457 Dallas, Texas 75235 469-585-7613 972-620-9830 fax arthurb@flash.net July 13, 2005 Dr. Jan Simoni Department of Surgery Texas Tech Health Science Center 3601 4th Street Stop 8312...Advisory Services Agreement • April 4th, 2006 • Hemobiotech Inc • Biological products, (no disgnostic substances)
THE SECURITIES REPRESENTED BY THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("1933 ACT") OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE...Warrant Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENTDirector and Officer Indemnification Agreement • January 18th, 2005 • Hemobiotech Inc • Delaware
Exhibit 10.10 Confidential portions of this Agreement have been omitted and filed separately with the Commission subject to a request for confidential treatment. [GRAPHIC OMITTED] TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER School of Medicine...Joint Project Agreement • April 15th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances)
EX-10.5 EMPLOYMENT SEPARATION AND RELEASE AGREEMENT This Employment Separation and Release Agreement (the "Agreement") is made and entered into as of July 15, 2004 by and between Hemobiotech Inc., a Delaware corporation (the "Company" or the...Employment Separation and Release Agreement • January 18th, 2005 • Hemobiotech Inc • Texas
Exhibit 10.9 SPONSORED RESEARCH AGREEMENT THIS AGREEMENT, by and between Texas Tech University Health Sciences Center (hereinafter referred to as HSC) and HemoBioTech, having a principal place of business at 15889 Preston Road, Suite 2006, Dallas,...Sponsored Research Agreement • May 13th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances) • Texas
STOCK AND NOTE PURCHASE AGREEMENTStock and Note Purchase Agreement • May 27th, 2010 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Stock and Note Purchase Agreement (this “Agreement”) is entered into as of the date set forth on the signature page hereof by and between HemoBioTech, Inc. a Delaware corporation (the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”).
SUBSCRIPTION AGREEMENTSubscription Agreement • March 28th, 2008 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Subscription Agreement (this “Agreement”), dated as of December [__], 2007, by and among HemoBioTech, Inc., a Delaware corporation (the “Company”), and each subscriber identified on the signature page hereto (each a “Subscriber” and collectively the “Subscribers”).
COMMON STOCK PURCHASE WARRANT To Purchase ______ Shares of Common Stock ofSecurities Agreement • December 29th, 2008 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) CERTIFIES that, for value received, _____________ (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance of this Warrant (the “Initial Exercise Date”) and on or prior to the five-year anniversary of the Effective Date (as defined below) (the “Termination Date”) but not thereafter, to subscribe for and purchase from HemoBioTech, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $____1 subject to adjustment thereunder.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 28th, 2008 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.10 Confidential portions of this Agreement have been omitted pursuant to an order granting confidential treatment issued by the Commission on May 11, 2005, pursuant to Rule 406 of the Securities Act of 1933, as amended. [GRAPHIC OMITTED]...Phase Ii Agreement • May 13th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances)
MODIFICATION, SETTLEMENT AND RELEASE AGREEMENTModification, Settlement and Release Agreement • March 9th, 2009 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • Texas
Exhibit 10.9 Confidential portions of this Agreement have been omitted and filed separately with the Commission subject to a request for confidential treatment. SPONSORED RESEARCH AGREEMENT THIS AGREEMENT, by and between Texas Tech University Health...Sponsored Research Agreement • April 15th, 2005 • Hemobiotech Inc • Biological products, (no disgnostic substances) • Texas
ContractSubordinated Promissory Note • May 27th, 2010 • Hemobiotech, Inc. • Biological products, (no disgnostic substances) • New York
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO INTEREST IN THIS NOTE MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, (ii) TO THE EXTENT APPLICABLE, PURSUANT TO RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT), OR (iii) AN EXEMPTION FROM REGISTRATION UNDER THE ACT WHERE THE HOLDER HAS FURNISHED TO THE COMPANY AN OPINION OF ITS COUNSEL THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT IS AVAILABLE.
SERVICE AGREEMENT Rev. 04-22-04 FOP This Agreement is dated NOVEMBER 23, 2004, and is entered into in Dallas, TEXAS by and between JPM-CEO Partners, Ltd. managed by Dallas Metro Suites, Inc. d.b.a. CEO JP Morgan International Plaza (hereinafter "CEO")...Service Agreement • January 18th, 2005 • Hemobiotech Inc
